can semaglutide cause kidney problems In the FLOW trial, researchers assessed whether the glucagon-like peptide 1 receptor agonist was effective in preventing progression of disease in patients with type 2 diabetes and chronic kidney disease FLOW trial Ozempic® (semaglutide injection)

Its user-friendly design promotes consistent usage, ensuring better adherence to the weight loss regimen

Last audited 2026-04-15

[9394] found that intravenous infusion of GLP-RA exenatide prior to revascularization in patients with ST-segment elevation myocardial infarction (MI) reduced reperfusion injury and final infarct size, compared with placebo treatment and Woo et al

Despite this mild increase in heart rate, large-scale cardiovascular outcome trials have consistently demonstrated robust major adverse cardiovascular event (MACE) reductions, indicating that this mild tachycardia does not translate to increased cardiovascular risk for most subjects

Any substantial weight loss can include both fat mass and lean mass